Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations

JCO PRECISION ONCOLOGY

LIPPINCOTT WILLIAMS & WILKINS

1. Loxo Oncology (Stamford, CT)
2. Cannonball Kids' Cancer
3. National Cancer Institute [K12CA184746, P30CA008748]
4. American Lebanese Syrian Associated Charities